[go: up one dir, main page]

ATE65395T1 - Acetylcystein enthaltendes, festes, wasserloeslisches arzneimittel. - Google Patents

Acetylcystein enthaltendes, festes, wasserloeslisches arzneimittel.

Info

Publication number
ATE65395T1
ATE65395T1 AT89107755T AT89107755T ATE65395T1 AT E65395 T1 ATE65395 T1 AT E65395T1 AT 89107755 T AT89107755 T AT 89107755T AT 89107755 T AT89107755 T AT 89107755T AT E65395 T1 ATE65395 T1 AT E65395T1
Authority
AT
Austria
Prior art keywords
containing solid
medicinal product
solid water
acetylcysteine
soluble medicinal
Prior art date
Application number
AT89107755T
Other languages
English (en)
Inventor
Paolo Lualdi
Original Assignee
Ibsa Inst Biochimique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ibsa Inst Biochimique Sa filed Critical Ibsa Inst Biochimique Sa
Application granted granted Critical
Publication of ATE65395T1 publication Critical patent/ATE65395T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT89107755T 1988-05-05 1989-04-28 Acetylcystein enthaltendes, festes, wasserloeslisches arzneimittel. ATE65395T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1681/88A CH674940A5 (de) 1988-05-05 1988-05-05
EP89107755A EP0340662B1 (de) 1988-05-05 1989-04-28 Acetylcystein enthaltendes, festes, wasserlöslisches Arzneimittel

Publications (1)

Publication Number Publication Date
ATE65395T1 true ATE65395T1 (de) 1991-08-15

Family

ID=4216104

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89107755T ATE65395T1 (de) 1988-05-05 1989-04-28 Acetylcystein enthaltendes, festes, wasserloeslisches arzneimittel.

Country Status (4)

Country Link
EP (1) EP0340662B1 (de)
AT (1) ATE65395T1 (de)
CH (1) CH674940A5 (de)
DE (1) DE68900152D1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE125702T1 (de) * 1990-10-19 1995-08-15 Spirig Ag Feste, schnell-lösliche arzneimittelzubereitung enthaltend s-(carboxymethyl)-l-cystein und/oder n-acetylcystein.
DE4233817C1 (de) * 1992-10-07 1994-02-24 Kabi Pharmacia Gmbh Verpackungsmaterial für ein gasfreisetzendes Produkt
IT1256616B (it) * 1992-12-02 1995-12-12 Zambon Spa Sciroppo contenente n-acetil-cisteina
US5807894A (en) * 1992-12-02 1998-09-15 Zambon Group S.P.A. Syrup containing N-acetyl-cysteine
DE69920567T2 (de) * 1998-03-31 2005-10-06 Shiseido Co. Ltd. Methode zur Verhütung des Körpergeruchs von alten Leute
US20080146579A1 (en) * 2006-12-15 2008-06-19 N.V. Nutricia Treatment of patients with chronic pulmonary diseases and nutritional compositions therefore
TR200900881A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş stabil farmasötik bileşimler
TR200900882A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş, bıyoyararlanımı yüksek farmasotık bileşimler.
GR1007236B (el) * 2009-12-07 2011-04-08 Uni-Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Αβεε Με Δ.Τ. Uni-Pharma Abee, Νεα φαρμακευτικη συνθεση κοκκιων ν - ακετυλοκυστεϊνης και μεθοδος παραγωγης αυτων
EP3505153B1 (de) 2017-12-31 2021-03-24 Abdi Ibrahim Ilac Sanayi ve Ticaret A.S. Pharmazeutische zusammensetzung mit acetylcystein, die frei von methylparaben und propylparaben ist

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE760006A (fr) * 1969-12-09 1971-05-17 Laevosan Ges C F Boehringer & Succedane de sucre a base de saccharine, pauvre en calories
DE3441862A1 (de) * 1984-11-13 1986-05-15 J. Ulrich 1000 Berlin Kuley Zubereitung aus zuckeraustauschmitteln und suessungsmitteln
CH666814A5 (it) * 1986-07-24 1988-08-31 Inpharzam Int Sa Composizione farmaceutica idrosolubile contenente n-acetil-cisteina.

Also Published As

Publication number Publication date
EP0340662B1 (de) 1991-07-24
EP0340662A1 (de) 1989-11-08
DE68900152D1 (de) 1991-08-29
CH674940A5 (de) 1990-08-15

Similar Documents

Publication Publication Date Title
NO170126C (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater i form av suspensjoner som inneholder sucralfat
DE3686483D1 (de) Arzneimittel.
ATE163849T1 (de) Arzneimittel enthaltend als wirkstoff r-alpha- liponsäure oder s-alpha-liponsäure
ATE74003T1 (de) Waessriges pharmazeutisches praeparat.
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
FR2367053A1 (fr) Nouveaux derives de phenoxy-amino-propanol, leur preparation et leur application en tant que medicaments
DE3579128D1 (de) 13-cis-vitamin-a-saeure als wirksubstanz enthaltende arzneimittel.
IL55274A (en) 4-(2,6-dihydroxy-4-(dimethylheptyl)phenyl)substituted 2-pinen-10-ol and pinane derivatives,their preparation and pharmaceutical compositions comprising them
FR2392971A1 (fr) Derives de l'acide prostanoique, leur preparation et medicament contenant ces substances
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
IT1190824B (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
KR890015742A (ko) 이병치료용 국소 제제
ATE65395T1 (de) Acetylcystein enthaltendes, festes, wasserloeslisches arzneimittel.
SE8600658D0 (sv) Novel composition of matter
GB2021409A (en) Pharmaceutical composition
ATE32882T1 (de) Phenylnonatetraensaeurederivate, ihre herstellung und pharmazeutische praeparate mit diesen derivaten.
ATE22005T1 (de) Cremegrundlage.
NO883986D0 (no) Fremgangsmaate for fremstilling av n-(substituert alkyliden)-1,2,3,4-tetrahydro-9-akridinaminer og anvendelse derav som medikamenter.
HUP9702348A2 (hu) Új, véralvadásgátló hatású glikozidok és az ezeket tartalmazó gyógyszerkészítmények
ATE88629T1 (de) Kosmetische un paramedizinische praeparate.
IT8024152A0 (it) Derivati dell'1,1,2-trifenilpropano e dell'1,1,2-trifenilpropene, procedimento per la loro preparazione e composizioni farmaceutiche contenenti i composti
IT8521528A0 (it) Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo diidrossi-1,8fenil-10 antrone-9, e procedimentodi preparazione dell'ingrediente attivo.
LU81501A1 (fr) Compositions pharmaceutiques comprenant de la trimethoprime,ainsi que des derives d'acides n-ethyl-gamma-pyridone-3-carboxyliques
FR2394539A1 (fr) Nouveaux derives substitues en position 15 d'o-pentanorprostaglandine et leur utilisation comme medicament
IT1196494B (it) Derivati dell'acito cef-3-em-4-carbossilico,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties